Publisher: Bentham Science Publishers
E-ISSN: 1873-4286|21|4|459-465
ISSN: 1381-6128
Source: Current Pharmaceutical Design, Vol.21, Iss.4, 2015-02, pp. : 459-465
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Inflammatory cardiomyopathy is a term used for left ventricular systolic dysfunction associated with myocarditis. In order to establish definitely the diagnosis, an endomyocardial biopsy (EMB) must be performed. Based on the results of EMB analysis, specific treatment may be added to conventional heart failure therapy. Immunosuppressive therapy in patients with non-viral inflammatory cardiomyopathy has been shown to be effective, and there is also some evidence that antiviral or antimicrobial therapy may be beneficial.
Related content
By Yang Li L Arab Sara Liu Peter Stewart Duncan J Husain Mansoor
Canadian Journal of Physiology and Pharmacology, Vol. 83, Iss. 1, 2005-01 ,pp. :
Inflammatory Disorders and Atherosclerosis: New Therapeutic Approaches
Current Pharmaceutical Design, Vol. 17, Iss. 37, 2011-12 ,pp. :
Vitamin D: New Roles and Therapeutic Potential in Inflammatory Bowel Disease
Current Drug Metabolism, Vol. 13, Iss. 9, 2012-11 ,pp. :